Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Investors Give ISIS The Cold Shoulder
Forbes
Wednesday, February 10, 2010 - 6:44pm
tags:
Isis Pharmaceuticals, Genzyme, mipomersen
Boston Scientific Narrows Loss on Higher Sales
Bloomberg
Wednesday, February 10, 2010 - 6:43pm
tags:
Boston Scientific, earnings
Vioxx Lawsuits: What’s Been Settled, What’s Still Going?
WSJ Online
Wednesday, February 10, 2010 - 6:35pm
tags:
Vioxx, Merck, settlements, lawsuits
The art of the deal, Sanofi-style
Fierce Pharma
Wednesday, February 10, 2010 - 11:08am
tags:
Sanofi, M&A
Rexahn: The Undiscovered Biotech
Seeking Alpha
Wednesday, February 10, 2010 - 10:42am
tags:
Rexahn, Teva Pharmaceuticals, Pfizer, Eli Lilly, GSK
Icahn's Smiling -- Should We Be?
Motley Fool
Wednesday, February 10, 2010 - 10:26am
tags:
Carl Icahn, Biogen Idec
Medicare Pay Cuts to Doctors: The Latest Patch
WSJ Online
Wednesday, February 10, 2010 - 10:25am
tags:
Medicare, reimbursement
Boehringer to Buy Japanese Consumer-Drug Producer SSP
Bloomberg
Wednesday, February 10, 2010 - 10:22am
tags:
Boehringer Ingelheim, Japan, M&A, SSP
Drug stocks dip; Isis tumbles on drug data
Marketwatch
Wednesday, February 10, 2010 - 10:21am
tags:
drug stocks, Isis Pharmaceuticals
Sanofi-Aventis chops into R&D budget, drops cancer drug
Fierce Biotech
Wednesday, February 10, 2010 - 9:37am
tags:
Sanofi, R&D
Alexza, Biovail to commercialize psychiatric drug
Marketwatch
Wednesday, February 10, 2010 - 9:35am
tags:
Biovail, Alexza, bipolar disorder, schizophrenia
Genzyme, Isis report positive study on heart drug
Marketwatch
Wednesday, February 10, 2010 - 9:29am
tags:
Isis Pharmaceuticals, Genzyme, mipomersen, cholesterol
Amgen Gets More Good Data with Bone Drug Prolia, but Other Risks Await
BNET Pharma
Wednesday, February 10, 2010 - 9:01am
tags:
Amgen, Prolia, Novartis, Zometa, denosumab
Elan expects rare operating profit in 2010
Reuters
Wednesday, February 10, 2010 - 9:00am
tags:
Elan, earnings, guidance
Merck to Change Safety Procedures, Pay Fees to End Vioxx Suits
Bloomberg
Wednesday, February 10, 2010 - 7:47am
tags:
settlements, Merck, Vioxx
Cel-Sci Drops Mystery Partner
TheStreet.com
Wednesday, February 10, 2010 - 7:46am
tags:
Cel-Sci
Sanofi-Aventis Q4 profit up on swine flu vaccines
Yahoo/AP
Wednesday, February 10, 2010 - 7:42am
tags:
Sanofi, earnings
UK court overturns GSK patent for lupus drug
FT.com
Tuesday, February 9, 2010 - 6:28pm
tags:
GSK, patents, UK, Human Genome Sciences, Eli Lilly, belimumab, lupus
Seattle Genetics 4Q loss narrows on higher revenue
Yahoo/AP
Tuesday, February 9, 2010 - 6:27pm
tags:
Seattle Genetics, earnings
Ligand posts 4Q profit as charge comes off books
Yahoo/AP
Tuesday, February 9, 2010 - 6:26pm
tags:
Ligand, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.